Survey of hypoglycemia unawareness using CGM in type 2 diabetes with high risk of severe hypoglycemia

Survey of hypoglycemia unawareness using CGM in type 2 diabetes with high risk of severe hypoglycemia - Hypoglycemia unawareness using CGM in type 2 diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000048447

Enrollment

300

Registered

2022-07-26

Start date

2022-07-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type 2 diabetes with high risk of severe hypoglycemia: 65 years or older, HbA1c <7.5%, treatment with Sulfonyl Urea or insulin. Supplement: Decreased renal function (eGFR <60 ml / min / 1.73 m2), history of severe hypoglycemia, It is even more desirable if there is hypoglycemia unawareness.

Exclusion criteria

Exclusion criteria: Current treatment with CGM. Skin trouble due to CGM in the past

Design outcomes

Primary

Measure	Time frame
Time below range (level 1; glucose < 56 mg/dL, and 2; glucose < 54 mg/dL) during whole day, day time and night time.	—

Countries

Japan

Contacts

Public ContactMunehide Matsuhisa

Tokushima University Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences

matuhisa@tokushima-u.ac.jp0886337587

Outcome results